BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11937525)

  • 1. Selective requirement for CD40-CD154 in drug-induced type 1 versus type 2 responses to trinitrophenyl-ovalbumin.
    Nierkens S; van Helden P; Bol M; Bleumink R; van Kooten P; Ramdien-Murli S; Boon L; Pieters R
    J Immunol; 2002 Apr; 168(8):3747-54. PubMed ID: 11937525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.
    Hayakawa Y; Takeda K; Yagita H; Van Kaer L; Saiki I; Okumura K
    J Immunol; 2001 May; 166(10):6012-8. PubMed ID: 11342617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential requirement for CD28/CTLA-4-CD80/CD86 interactions in drug-induced type 1 and type 2 immune responses to trinitrophenyl-ovalbumin.
    Nierkens S; Aalbers M; Bol M; Bleumink R; van Kooten P; Boon L; Pieters R
    J Immunol; 2005 Sep; 175(6):3707-14. PubMed ID: 16148116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diesel exhaust, carbon black, and silica particles display distinct Th1/Th2 modulating activity.
    van Zijverden M; van der Pijl A; Bol M; van Pinxteren FA; de Haar C; Penninks AH; van Loveren H; Pieters R
    Toxicol Appl Pharmacol; 2000 Oct; 168(2):131-9. PubMed ID: 11032768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential requirement for the CD40-CD154 costimulatory pathway during Th cell priming by CD8 alpha+ and CD8 alpha- murine dendritic cell subsets.
    Yasumi T; Katamura K; Yoshioka T; Meguro TA; Nishikomori R; Heike T; Inobe M; Kon S; Uede T; Nakahata T
    J Immunol; 2004 Apr; 172(8):4826-33. PubMed ID: 15067060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
    Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
    Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential requirements for expression of CD80/86 and CD40 on B cells for T-dependent antibody responses in vivo.
    Lumsden JM; Williams JA; Hodes RJ
    J Immunol; 2003 Jan; 170(2):781-7. PubMed ID: 12517941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary ribonucleotides increase antigen-specific type 1 T-helper cells in the regional draining lymph nodes in young BALB/cJ mice.
    Jyonouchi H; Sun S; Winship T; Kuchan MJ
    Nutrition; 2003 Jan; 19(1):41-6. PubMed ID: 12507638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40, but not CD154, expression on B cells is necessary for optimal primary B cell responses.
    Lee BO; Moyron-Quiroz J; Rangel-Moreno J; Kusser KL; Hartson L; Sprague F; Lund FE; Randall TD
    J Immunol; 2003 Dec; 171(11):5707-17. PubMed ID: 14634078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD154 plays a central role in regulating dendritic cell activation during infections that induce Th1 or Th2 responses.
    Straw AD; MacDonald AS; Denkers EY; Pearce EJ
    J Immunol; 2003 Jan; 170(2):727-34. PubMed ID: 12517934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dynamic alteration of CD154/CD40 and its effects on Th1/Th2 polarization in inducible co-stimulator ligand knockout mice infected with Schistosoma japonicum].
    Wang Y; Xia CM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Dec; 47(6):898-904. PubMed ID: 26679647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the oligomeric requirement for signaling by CD40 using soluble multimeric forms of its ligand, CD154.
    Haswell LE; Glennie MJ; Al-Shamkhani A
    Eur J Immunol; 2001 Oct; 31(10):3094-100. PubMed ID: 11592086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28.
    Ryan M; McCarthy L; Rappuoli R; Mahon BP; Mills KH
    Int Immunol; 1998 May; 10(5):651-62. PubMed ID: 9645613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CD154/CD40 interaction required for retrovirus-induced murine immunodeficiency syndrome is not mediated by upregulation of the CD80/CD86 costimulatory molecules.
    Green KA; Cook WJ; Sharpe AH; Green WR
    J Virol; 2002 Dec; 76(24):13106-10. PubMed ID: 12438641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD80, but not CD86 were up-regulated on the spleen-derived dendritic cells from OVA-sensitized and challenged BALB/c mice.
    Cheng X; Wang C; Qian G; Zhu B
    Immunol Lett; 2003 Oct; 89(1):31-8. PubMed ID: 12946862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40-CD154 interaction and IFN-gamma are required for IL-12 but not prostaglandin E2 secretion by microglia during antigen presentation to Th1 cells.
    Aloisi F; Penna G; Polazzi E; Minghetti L; Adorini L
    J Immunol; 1999 Feb; 162(3):1384-91. PubMed ID: 9973393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosally induced systemic T cell unresponsiveness to ovalbumin requires CD40 ligand-CD40 interactions.
    Kweon MN; Fujihashi K; Wakatsuki Y; Koga T; Yamamoto M; McGhee JR; Kiyono H
    J Immunol; 1999 Feb; 162(4):1904-9. PubMed ID: 9973457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune intervention by CD154 blockade prevents T cell retention and effector function in the target organ.
    Howard LM; Miller SD
    J Immunol; 2001 Feb; 166(3):1547-53. PubMed ID: 11160195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary ribonucleotides modulate type 1 and type 2 T-helper cell responses against ovalbumin in young BALB/cJ mice.
    Jyonouchi H; Sun S; Winship T; Kuchan MJ
    J Nutr; 2001 Apr; 131(4):1165-70. PubMed ID: 11285320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo.
    Kishimoto K; Dong VM; Issazadeh S; Fedoseyeva EV; Waaga AM; Yamada A; Sho M; Benichou G; Auchincloss H; Grusby MJ; Khoury SJ; Sayegh MH
    J Clin Invest; 2000 Jul; 106(1):63-72. PubMed ID: 10880049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.